Nama's AI scorecard currently rates Ryan Specialty Hold (5.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is RYAN's P/E ratio?

Ryan Specialty trades at a trailing price-to-earnings ratio of 22.0.

When does RYAN report earnings?

Ryan Specialty's next scheduled report is on Feb 11, 2027. Analysts expect EPS of $0.48.

What is the RYAN price target?

The median analyst price target from 16 analysts is $47.00, with a range of $40.00 – $76.00.

Is RYAN Shariah compliant?

Nama's AAOIFI-style screen reads Ryan Specialty as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does RYAN pay a dividend?

Yes — Ryan Specialty's dividend yield is 1.1%.

Nama Insights

Ryan Specialty (RYAN)

Financial Services · Insurance Specialty · NYSE

Ryan Specialty (RYAN) is a Financial Services company in the Insurance Specialty industry. It has a market capitalization of $12.10B and a trailing price-to-earnings ratio of 22.0. Over the most recent reported fiscal year, revenue grew 21.3%. Nama's AI scorecard rates it Hold, 5.7 out of 10. On 12-month momentum it ranks in the trailing band of its market.

AI scorecard

Hold · 5.7/10

The sections balance. As of Nov 7, 2026.

Momentum

Trailing · -34.0% over 12 months ex. last

Bottom 20% of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-38.1%

How far the last close sits under the highest price of the past five years.

Market cap	$12.10B
Trailing P/E	22.0
Price / book	11.4
Price / sales	3.8
FCF yield	—
Dividend yield	1.1%
Gross margin	41.1%
Operating margin	19.1%
Net margin	3.7%
Revenue growth (YoY)	+21.3%
Revenue growth (3-yr annual)	+20.9%
EPS growth (YoY)	+10.1%
FCF/share growth (YoY)	—
Beta	0.6
Exchange	NYSE
Sector	Financial Services
Industry	Insurance Specialty

RYAN earnings

Next report: Feb 11, 2027 (Q4 2026, EPS estimate $0.48). Beat the EPS estimate in 3 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 29, 2026	$0.51	$0.49	+4.1%	$789.96M
Q2 2026	Jul 30, 2026	$0.74	$0.60	+23.3%	$916.65M
Q1 2026	Apr 30, 2026	$0.47	$0.43	+9.3%	$795.23M
Q4 2025	Feb 12, 2026	$0.45	$0.49	-8.2%	$751.21M

RYAN analyst price target

Median target $47.00 from 16 analysts, ranging $40.00 – $76.00.

Insurance Specialty peers

Ticker	Company	Market cap	P/E
FNF	Fidelity National Financial	$11.76B	8.7
AXS	AXIS Capital	$7.60B	8.5
FAF	First American Financial	$6.84B	9.3
ACT	Enact	$6.38B	9.5
ESNT	Essent Group	$5.70B	8.7
MTG	MGIC Investment	$5.69B	8.8
RDN	Radian Group	$4.67B	7.3
AGO	Assured Guaranty	$3.23B	9.2

Explore live RYAN data on Nama Insights →

RYAN FAQ

Is RYAN a buy?: Nama's AI scorecard currently rates Ryan Specialty Hold (5.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is RYAN's P/E ratio?: Ryan Specialty trades at a trailing price-to-earnings ratio of 22.0.
When does RYAN report earnings?: Ryan Specialty's next scheduled report is on Feb 11, 2027. Analysts expect EPS of $0.48.
What is the RYAN price target?: The median analyst price target from 16 analysts is $47.00, with a range of $40.00 – $76.00.
Is RYAN Shariah compliant?: Nama's AAOIFI-style screen reads Ryan Specialty as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does RYAN pay a dividend?: Yes — Ryan Specialty's dividend yield is 1.1%.